Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
Rev Neurol (Paris) ; 169(8-9): 640-9, 2013.
Article de Anglais | MEDLINE | ID: mdl-24008049

RÉSUMÉ

In autoimmune Myasthenia Gravis (MG), a neuromuscular disease generally mediated by autoantibodies against the acetylcholine receptor (AChR), the muscle is the target organ of the autoimmune attack, while the thymus seems to be the primary production site of the autoantibodies. In the majority of patients with anti-AChR antibodies, it is characterized by the presence of germinal centers, which contain B cells that produce anti-AChR antibodies. In this review, we summarize recent results regarding neoangiogenic processes, cell infiltration and modified chemokine expression in the MG thymus, which are typical features of secondary lymphoid organs. The structural and functional changes in the MG thymus therefore allow us to declare it to be an archetype for tertiary lymphoid neogenesis providing optimal settings for the interaction between lymphocytes and antigen presenting cells in order to elicit an immune response. We further discuss factors that may have a key role in the transformation of the MG thymus into a tertiary lymphoid organ, such as IFN type I and dsRNA signaling. These factors could also be of importance in other autoimmune diseases, especially those characterized by tertiary lymphoid neogenesis.


Sujet(s)
Tissu lymphoïde/immunologie , Myasthénie/physiopathologie , Thymus (glande)/physiologie , Animaux , Autoanticorps/métabolisme , Humains , Tissu lymphoïde/croissance et développement , Myasthénie/anatomopathologie , Thymus (glande)/anatomopathologie , Hyperplasie du thymus/immunologie , Hyperplasie du thymus/métabolisme , Maladies virales/complications , Maladies virales/immunologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE